Characterisation of invasive group B streptococci based on investigation of surface proteins and genes encoding surface proteins

Clinical Microbiology and Infection

Volumn 14, Issue 1, 2008, Pages 66-73

  Persson, Elisabet ^a   Berg, S ^a   Bevanger, L ^b   Bergh, K ^b   Valso Lyng R ^c   Trollfors, B ^a  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Genotype; Group B streptococcus; Serotype; Streptococcus agalactiae; Surface protein; Vaccine candidates

Indexed keywords

BACTERIAL PROTEIN; MEMBRANE PROTEIN; MICROORGANISM PROTEIN; MONOCLONAL ANTIBODY; PROTEIN ALP1; PROTEIN ALP2; PROTEIN ALP3; PROTEIN ALPHA C; PROTEIN BETA C; PROTEIN C; PROTEIN RIB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM ISOLATE; FEMALE; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; SPECIES INVASION; STREPTOCOCCUS AGALACTIAE; SWEDEN;

STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 36849008494     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01877.x     Document Type: Article

References (49)

1. Schrag SJ, Zywicki S, Farley MM et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 432: 15-20.
2. Ekelund K, Konradsen HB. Invasive group B streptococcal disease in infants: A 19-year nationwide study. Serotype distribution, incidence and recurrent infection. Epidemiol Infect 2004; 132: 1083-1090.
3. Weisner A, Johnson A, Lamegni T et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 2004; 43: 1203-1208.
4. Straková L, Motlová J. Active surveillance of early onset disease due to group B streptococci in newborns. Ind J Med Res 2004; 119 (suppl): 205-207.
5. Persson E, Berg S, Trollfors B et al. Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin Microbiol Infect 2004; 10: 791-796.
6. Davies H, Raj S, Adair C, Robinson J, McGeer A, The Alberta GBS study group. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: Implications for vaccine formulation. Pediatr Infect Dis J 2001; 20: 879-884.
7. Lyytikäinen O, Nuorti JP, Halmesmäki E et al. Invasive group B streptococcal infections in Finland: A population-based study. Emerg Infect Dis 2003; 9: 469-473.
8. Farley MM. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 2001; 43: 556-561.
9. Edwards MS, Baker CJ. GroupB streptococcal infections in elderly adults. Clin Infect Dis 2005; 43: 843-847.
10. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294: 753-756.
11. Baker CJ, Rench MA, Paoletti LC, Edwards MS. Dose-response to type V groupB streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 2007; 25: 55-63.
12. Baker CJ, Rench MA, Fernandez M, Paoletti LC, Kasper DL, Edwards MS. Safety and immunogenicity of a bivalent groupB streptococcal conjugate vaccine for serotypesII and III. J Infect Dis 2003; 188: 66-73.
13. Baker CJ, Rench M, McInnes P. Immunization of pregnant women with group B streptococcal typeIII capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003; 21: 4368-4372.
14. Wilkinson HW, Eagon RG. Type-specific antigens of group B typeIc streptococci. Infect Immun 1971; 4: 596-604.
15. Bevanger L. The Ibc proteins of group B streptococci: Isolation of the α and β antigens by immunosorbent chromatography and test for human serum antibodies against the two antigens. Acta Pathol Microbiol Immunol Scand (B) 1985; 93: 113-119.
16. Smith BL, Flores A, Dechaine J, Krepela J, Bergdall A, Ferrieri P. Gene encoding the group B streptococcal protein R4, its presence in clinical reference laboratory isolates and R4 protein pepsin sensitivity. Ind J Med Res 2004; 119 (suppl): 213-220.
17. Bevanger L, Kvam AI, Maeland JA. A Streptococcus agalactiae R protein analysed by polyclonal and monoclonal antibodies. APMIS 1995; 103: 732-736.
18. Lachenauer CS, Creti R, Michel JL, Madoff LC. Mosaicism in the alpha-like protein genes of group B streptococci. Proc Natl Acad Sci USA 2000; 97: 9632-9643.
19. Lachenauer CS, Madoff LC. A protective surface protein from type V groupB streptococci shares N-terminal sequence homology with the alpha C protein. Infect Immun 1996; 64: 4255-4260.
20. Maeland JA, Bevanger L, Valsö-Lyng R. Antigenic determinants of alpha-like proteins of Streptococcus agalactiae. Clin Diagn Lab Immunol 2004; 11: 1035-1039.
21. Bevanger L, Naess AI. Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol Microbiol Immunol Scand (B) 1985; 93: 121-124.
22. Lancefield R, Perlmann G. Multiple mouse protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med 1975; 143: 165-179.
23. Berg S, Trollfors B, Lagergård T, Zackrisson G, Claesson BA. Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. Clin Microbiol Infect 2000; 6: 9-13.
24. Centers for Disease Control. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR 1996; 45 (RR-7): 1-24.
25. Moyo SR, Maeland JA, Bevanger L. Comparison of three different methods in monoclonal antibody-based detection of Streptococcus agalactiae protein serotype markers. APMIS 1999; 107: 263-269.
26. Creti R, Fabretti F, Orefici G, von Hunolstein C. Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes. J Clin Microbiol 2004; 43: 1326-1432.
27. Kong F, Gowan S, Martin D, James G, Gilbert G. Molecular profiles of group B streptococcal surface protein antigen genes: Relationship to molecular serotypes. J Clin Microbiol 2002; 43: 620-626.
28. Maeland JA, Brakstad OG, Bevanger L, Krokstad S. Distribution and expression of bca, the gene encoding the c alpha protein, by Streptococcus agalactiae. J Med Microbiol 2000; 49: 193-198.
29. Lancefield R. Serological differentiaton of specific types of bovine hemolytic streptococci (group B). J Exp Med 1934; 59: 441-458.
30. Slotved HC, Elliott J, Thompson T, Konradsen HB. Latex assay for serotyping of group B Streptococcus isolates. J Clin Microbiol 2003; 41: 4445-4447.
31. Håkansson S, Burman L, Henrichsen J, Holm S. Novel coagglutination method for serotyping group B streptococci. J Clin Microbiol 1992; 30: 3268-3269.
32. Zhao Z, Kong F, Gilbert GL. Reverse line blot assay for direct identification of seven Streptococcus agalactiae major surface protein antigen genes. Clin Vaccine Immunol 2006; 13: 145-149.
33. Skjaervold NK, Bergh K, Bevanger L. Distribution of PFGE types of invasive Norwegian group B streptococci in relation to serotypes. Ind J Med Res 2004; 119: 201-204.
34. Quentin R, Huet H, Wang FS, Geslin P, Goudeau A, Selander R. Characterisation of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: Identification of multiple virulent clone families that cause invasive neonatal disease. J Clin Microbiol 1995; 33: 2576-2581.
35. Jones N, Bohnsack J, Takahashi S et al. Multilocus sequence typing system for groupB Streptococcus. J Clin Microbiol 2003; 41: 2530-2536.
36. Luan SL, Granlund M, Sellin M, Lagergård T, Spatt B, Norgren M. Multilocus sequence typing of Swedish invasive group B Streptococcus isolates indicates a neonatally associated genetic lineage and capsular switching. J Clin Microbiol 2005; 43: 3727-3733.
37. Zeng X, Kong F, Morgan J, Gilbert G. Evaluation of a multiplex PCR-based reverse line blot-hybridization assay for identification of serotype and surface protein antigens of Streptococcus agalactiae. J Clin Microbiol 2006; 44: 3822-3825.
38. Wen L, Wang Q, Lli Y et al. Use of serotype-specific DNA microarray for identification of groupB Streptococcus (Streptococcus agalactiae). J Clin Microbiol 2006; 44: 1447-1452.
39. Wästfelt M, Stålhammar-Carlemalm M, Delisse AM, Cabezon T, Lindahl G. Identification of a family of streptococcal surface proteins with extremely repetitive structure. J Biol Chem 1996; 271: 18892-18897.
40. Ferrieri P, Baker CJ, Hillier SL, Flores AE. Diversity of surface protein expression in group B streptococcal colonizing and invasive isolates. Ind J Med Res 2004; 119: 191-196.
41. Manning SD, Ki M, Marrs C et al. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis 2006; 6: 116.
42. Maeland JA, Bevanger L, Valsoe-Lyng R. Immunological markers of the R4 protein of Streptococcus agalactiae. Clin Diagn Lab Immunol 2005; 12: 1305-1310.
43. Valentin-Weigand P, Chhatwal GS. Correlation of epithelial cell invasiveness of group B streptococci with clinical source of isolation. Microb Pathog 1995; 19: 83-91.
44. Madoff L, Michel J, Gong E, Kling D, Kasper D. Group B streptococci escape host immunity by deletion of the repeat elements of the alpha C protein. Proc Natl Acad Sci USA 1996; 96: 4332-4343.
45. Gravekamp C, Rosner B, Madoff LC. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice. Infect Immun 1998; 66: 4347-4354.
46. Gravekamp C, Kasper D, Paoletti L, Madoff L. Alpha C protein as a carrier for typeIII capsular polysaccharide and as a protective protein in group B streptococcal vaccines. Infect Immun 1999; 67: 2491-2496.
47. Larsson C, Holmgren J, Lindahl G, Bergquist C. Intranasal immunization of mice with group B streptococcal protein Rib and cholera toxin B subunit confers protection against lethal infection. Infect Immun 2004; 72: 1184-1187.
48. Martin D, Roux S, Gagnon E et al. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein. Infect Immun 2002; 70: 4897-4901.
49. Maione D, Immanculada M, Rinaudo CD et al. Identification of a universal group B Streptococcus vaccine by multiple genome screen. Science 2005; 309: 148-150.